Sana Biotechnology SANA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -147.4%-28.7pp | -118.7%-22.6pp | -96.1%+13.0pp | -109.1%-37.7pp | -71.4%+27.7pp | |
| Return on invested capital | -157.6%-27.6pp | -130%-19.9pp | -110.1%+7.2pp | -117.4%-33.7pp | -83.6%+31.1pp | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.6× | 1.9×-2.7× | 4.6×+2.1× | 2.5×-0.9× | 3.4×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.6×+0.1× | 0.5×+0.1× | 0.4×-0.3× | 0.7×+0.3× | 0.4×+0.1× | |
| Per Share | ||||||
| Book value per share | $0.43-32.2% | $0.64-15.3% | $0.75+45.8% | $0.51-41.6% | $0.88-18.9% | |
| Valuation | ||||||
| Market capitalization | $912.8M+55.1% | $1.08B+18.7% | $913.24M+36.3% | $669.9M+77.2% | $378.04M+3.9% | |
| Price / book | 7.7×+4.8× | 6.7×+2.1× | 4.7×-0.8× | 5.5×+3.7× | 1.8×+0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Sana Biotechnology's ratios come from?
- Every ratio is computed from Sana Biotechnology's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.